Orthobiologics Market Set to Reach $8.2 Billion by 2030, Viscosupplementation Segment Exhibiting Robust Growth [Yahoo! Finance]
Bioventus Inc. - Class A (BVS)
Company Research
Source: Yahoo! Finance
The global market for Orthobiologics estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$8.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030. Viscosupplementation, one of the segments analyzed in the Orthobiologics report, is projected to record 5.2% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Synthetic Orthobiologics segment is readjusted to a revised 3.5% CAGR for the next 8-year period. The Orthobiologics market in the U.S. is estimated at US$1.7 Billion in the year 2022. China , the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada , each forecast to grow at 3.9% and 3.5% respectively over the 2022-2030 period. Within Europe Germa
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M [Seeking Alpha]Seeking Alpha
- Bioventus Announces Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Neuromodulation Market projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study [Yahoo! Finance]Yahoo! Finance
BVS
Earnings
- 3/12/24 - Miss
BVS
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- BVS's page on the SEC website